Concepts (78)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lectins | 3 | 2007 | 5 | 0.370 |
Why?
|
| Complement Pathway, Mannose-Binding Lectin | 1 | 2007 | 1 | 0.290 |
Why?
|
| Lipoproteins, LDL | 1 | 2007 | 8 | 0.290 |
Why?
|
| C-Reactive Protein | 5 | 1988 | 102 | 0.180 |
Why?
|
| HIV | 2 | 2006 | 43 | 0.120 |
Why?
|
| Cell Adhesion Molecules | 3 | 2006 | 20 | 0.090 |
Why?
|
| Lectins, C-Type | 3 | 2006 | 46 | 0.090 |
Why?
|
| Receptors, Cell Surface | 3 | 2006 | 39 | 0.090 |
Why?
|
| HIV Envelope Protein gp120 | 3 | 2006 | 16 | 0.070 |
Why?
|
| Mannose-Binding Protein-Associated Serine Proteases | 1 | 2007 | 1 | 0.070 |
Why?
|
| Enzyme Precursors | 1 | 2007 | 2 | 0.070 |
Why?
|
| Acetylation | 1 | 2007 | 14 | 0.070 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2007 | 27 | 0.070 |
Why?
|
| Ligands | 1 | 2007 | 41 | 0.070 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2007 | 98 | 0.070 |
Why?
|
| Enzyme Activation | 1 | 2007 | 120 | 0.070 |
Why?
|
| Lymphocytes | 4 | 1988 | 63 | 0.070 |
Why?
|
| Receptors, Fc | 1 | 1986 | 9 | 0.070 |
Why?
|
| Polysaccharides | 1 | 2006 | 12 | 0.070 |
Why?
|
| Immune System | 1 | 2006 | 15 | 0.070 |
Why?
|
| Monocytes | 1 | 1986 | 64 | 0.070 |
Why?
|
| Neutrophils | 1 | 1986 | 110 | 0.060 |
Why?
|
| Marburgvirus | 1 | 2005 | 1 | 0.060 |
Why?
|
| Mannose-Binding Lectin | 1 | 2005 | 1 | 0.060 |
Why?
|
| Ebolavirus | 1 | 2005 | 6 | 0.060 |
Why?
|
| Gene Products, env | 1 | 2005 | 14 | 0.060 |
Why?
|
| Viral Envelope Proteins | 1 | 2005 | 15 | 0.060 |
Why?
|
| Mannose-Binding Lectins | 1 | 2005 | 2 | 0.060 |
Why?
|
| Carrier Proteins | 2 | 2006 | 106 | 0.060 |
Why?
|
| HIV-1 | 2 | 2000 | 236 | 0.060 |
Why?
|
| HIV Envelope Protein gp41 | 1 | 2000 | 12 | 0.040 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 2000 | 45 | 0.040 |
Why?
|
| Humans | 11 | 2007 | 28386 | 0.040 |
Why?
|
| Luminescent Measurements | 2 | 1986 | 21 | 0.030 |
Why?
|
| Tetradecanoylphorbol Acetate | 2 | 1986 | 40 | 0.030 |
Why?
|
| Immunoglobulin G | 2 | 1986 | 93 | 0.030 |
Why?
|
| Glycosylation | 2 | 2006 | 17 | 0.030 |
Why?
|
| Protein Binding | 2 | 2000 | 132 | 0.030 |
Why?
|
| Cell Line | 3 | 2005 | 280 | 0.020 |
Why?
|
| Antigens, Surface | 2 | 1988 | 13 | 0.020 |
Why?
|
| Human T-lymphotropic virus 1 | 1 | 1991 | 9 | 0.020 |
Why?
|
| Complement C1q | 1 | 1991 | 7 | 0.020 |
Why?
|
| Molecular Weight | 2 | 1988 | 29 | 0.020 |
Why?
|
| HIV Infections | 2 | 2006 | 488 | 0.020 |
Why?
|
| Flow Cytometry | 2 | 1988 | 116 | 0.020 |
Why?
|
| Complement Activation | 2 | 2005 | 10 | 0.020 |
Why?
|
| Zymosan | 1 | 1986 | 5 | 0.020 |
Why?
|
| Hot Temperature | 1 | 1986 | 19 | 0.020 |
Why?
|
| Structure-Activity Relationship | 1 | 1986 | 40 | 0.020 |
Why?
|
| Receptors, IgG | 1 | 1986 | 12 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 1986 | 58 | 0.020 |
Why?
|
| Oxygen Consumption | 1 | 1986 | 51 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2006 | 60 | 0.020 |
Why?
|
| Kinetics | 1 | 1986 | 194 | 0.020 |
Why?
|
| Bacterial Proteins | 1 | 2006 | 78 | 0.020 |
Why?
|
| Immunity, Cellular | 1 | 1986 | 31 | 0.020 |
Why?
|
| Complement System Proteins | 1 | 2005 | 8 | 0.020 |
Why?
|
| Binding, Competitive | 1 | 2005 | 24 | 0.020 |
Why?
|
| Neutralization Tests | 1 | 2005 | 10 | 0.020 |
Why?
|
| Animals | 2 | 2006 | 3780 | 0.010 |
Why?
|
| Collectins | 1 | 2000 | 1 | 0.010 |
Why?
|
| Immunity, Innate | 1 | 2000 | 58 | 0.010 |
Why?
|
| Epitopes | 2 | 1988 | 48 | 0.010 |
Why?
|
| Killer Cells, Natural | 2 | 1988 | 49 | 0.010 |
Why?
|
| Virus Replication | 1 | 1991 | 51 | 0.010 |
Why?
|
| Protein Conformation | 1 | 1988 | 74 | 0.000 |
Why?
|
| Antigens, Differentiation, B-Lymphocyte | 1 | 1988 | 1 | 0.000 |
Why?
|
| Antigen-Antibody Reactions | 1 | 1988 | 5 | 0.000 |
Why?
|
| HLA-DR Antigens | 1 | 1988 | 11 | 0.000 |
Why?
|
| Lymphoproliferative Disorders | 1 | 1988 | 14 | 0.000 |
Why?
|
| Cell Separation | 1 | 1988 | 29 | 0.000 |
Why?
|
| B-Lymphocytes | 1 | 1988 | 56 | 0.000 |
Why?
|
| Phenotype | 1 | 1988 | 313 | 0.000 |
Why?
|
| DNA Replication | 1 | 1986 | 10 | 0.000 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 1986 | 18 | 0.000 |
Why?
|
| Lymphocyte Activation | 1 | 1986 | 86 | 0.000 |
Why?
|
| Cells, Cultured | 1 | 1986 | 539 | 0.000 |
Why?
|
| Mice | 1 | 1986 | 1461 | 0.000 |
Why?
|